{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:03:14Z","timestamp":1784793794660,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43NS076060"],"award-info":[{"award-number":["R43NS076060"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35NS09730"],"award-info":[{"award-number":["R35NS09730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"DOI":"10.1038\/s44386-026-00060-7","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:20:26Z","timestamp":1784791226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel small molecule remyelination therapy for multiple sclerosis"],"prefix":"10.1038","volume":"3","author":[{"given":"Yan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brain","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars J. S.","family":"Knutsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Hamlyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Ling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Antel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Medicetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Trapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"60_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp, B. D. & Nave, K. A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 31, 247\u2013269, https:\/\/doi.org\/10.1146\/annurev.neuro.30.051606.094313 (2008).","journal-title":"Annu. Rev. Neurosci."},{"key":"60_CR2","doi-asserted-by":"publisher","unstructured":"Bross, M., Hackett, M. & Bernitsas, E. Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21124312 (2020).","DOI":"10.3390\/ijms21124312"},{"key":"60_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0022-510x(02)00069-2","volume":"206","author":"C Bjartmar","year":"2003","unstructured":"Bjartmar, C., Wujek, J. R. & Trapp, B. D. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206, 165\u2013171, https:\/\/doi.org\/10.1016\/s0022-510x(02)00069-2 (2003).","journal-title":"J. Neurol. Sci."},{"key":"60_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443\u2013448, https:\/\/doi.org\/10.1038\/nature11314 (2012).","journal-title":"Nature"},{"key":"60_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839\u2013855, https:\/\/doi.org\/10.1038\/nrn2480 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"60_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00019052-199906000-00008","volume":"12","author":"BD Trapp","year":"1999","unstructured":"Trapp, B. D., Ransohoff, R. & Rudick, R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 12, 295\u2013302, https:\/\/doi.org\/10.1097\/00019052-199906000-00008 (1999).","journal-title":"Curr. Opin. Neurol."},{"key":"60_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJM Franklin","year":"2017","unstructured":"Franklin, R. J. M. & Ffrench-Constant, C. Regenerating CNS myelin - from mechanisms to experimental medicines. Nat. Rev. Neurosci. 18, 753\u2013769, https:\/\/doi.org\/10.1038\/nrn.2017.136 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"60_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/acn3.55","volume":"1","author":"SY Leong","year":"2014","unstructured":"Leong, S. Y. et al. Heterogeneity of oligodendrocyte progenitor cells in adult human brain. Ann. Clin. Transl. Neurol. 1, 272\u2013283, https:\/\/doi.org\/10.1002\/acn3.55 (2014).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"60_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","volume":"116","author":"RJM Franklin","year":"2021","unstructured":"Franklin, R. J. M., Frisen, J. & Lyons, D. A. Revisiting remyelination: towards a consensus on the regeneration of CNS myelin. Semin Cell Dev. Biol. 116, 3\u20139, https:\/\/doi.org\/10.1016\/j.semcdb.2020.09.009 (2021).","journal-title":"Semin Cell Dev. Biol."},{"key":"60_CR10","doi-asserted-by":"publisher","first-page":"E11807","DOI":"10.1073\/pnas.1808064115","volume":"115","author":"ID Duncan","year":"2018","unstructured":"Duncan, I. D. et al. The adult oligodendrocyte can participate in remyelination. Proc. Natl. Acad. Sci. USA 115, E11807\u2013E11816, https:\/\/doi.org\/10.1073\/pnas.1808064115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","volume":"566","author":"MSY Yeung","year":"2019","unstructured":"Yeung, M. S. Y. et al. Dynamics of oligodendrocyte generation in multiple sclerosis. Nature 566, 538\u2013542, https:\/\/doi.org\/10.1038\/s41586-018-0842-3 (2019).","journal-title":"Nature"},{"key":"60_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2020.03.017","volume":"26","author":"B Neumann","year":"2020","unstructured":"Neumann, B. et al. Problems and pitfalls of identifying remyelination in multiple sclerosis. Cell Stem Cell 26, 617\u2013619, https:\/\/doi.org\/10.1016\/j.stem.2020.03.017 (2020).","journal-title":"Cell Stem Cell"},{"key":"60_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.neuron.2008.09.011","volume":"60","author":"TA Watkins","year":"2008","unstructured":"Watkins, T. A., Emery, B., Mulinyawe, S. & Barres, B. A. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60, 555\u2013569, https:\/\/doi.org\/10.1016\/j.neuron.2008.09.011 (2008).","journal-title":"Neuron"},{"key":"60_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1326-6-46","volume":"6","author":"JM Dean","year":"2011","unstructured":"Dean, J. M. et al. An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors. Mol. Neurodegener. 6, 46, https:\/\/doi.org\/10.1186\/1750-1326-6-46 (2011).","journal-title":"Mol. Neurodegener."},{"key":"60_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/science.aau5729","volume":"363","author":"SP Pasca","year":"2019","unstructured":"Pasca, S. P. Assembling human brain organoids. Science 363, 126\u2013127, https:\/\/doi.org\/10.1126\/science.aau5729 (2019).","journal-title":"Science"},{"key":"60_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei, F. et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat. Med 20, 954\u2013960, https:\/\/doi.org\/10.1038\/nm.3618 (2014).","journal-title":"Nat. Med"},{"key":"60_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nmeth.2105","volume":"9","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. A culture system to study oligodendrocyte myelination processes using engineered nanofibers. Nat. Methods 9, 917\u2013922, https:\/\/doi.org\/10.1038\/nmeth.2105 (2012).","journal-title":"Nat. Methods"},{"key":"60_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","volume":"12","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252\u2013264, https:\/\/doi.org\/10.1016\/j.stem.2012.12.002 (2013).","journal-title":"Cell Stem Cell"},{"key":"60_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107658","volume":"31","author":"MS Windrem","year":"2020","unstructured":"Windrem, M. S. et al. Human glial progenitor cells effectively remyelinate the demyelinated adult brain. Cell Rep. 31, 107658. https:\/\/doi.org\/10.1016\/j.celrep.2020.107658 (2020).","journal-title":"Cell Rep."},{"key":"60_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ana.20913","volume":"60","author":"L Steinman","year":"2006","unstructured":"Steinman, L. & Zamvil, S. S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60, 12\u201321, https:\/\/doi.org\/10.1002\/ana.20913 (2006).","journal-title":"Ann. Neurol."},{"key":"60_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.it.2006.02.007","volume":"27","author":"RM Ransohoff","year":"2006","unstructured":"Ransohoff, R. M. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. Trends Immunol. 27, 167\u2013168, https:\/\/doi.org\/10.1016\/j.it.2006.02.007 (2006).","journal-title":"Trends Immunol."},{"key":"60_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-540-73677-6_8","volume":"318","author":"WF Blakemore","year":"2008","unstructured":"Blakemore, W. F. & Franklin, R. J. Remyelination in experimental models of toxin-induced demyelination. Curr. Top. Microbiol Immunol. 318, 193\u2013212, https:\/\/doi.org\/10.1007\/978-3-540-73677-6_8 (2008).","journal-title":"Curr. Top. Microbiol Immunol."},{"key":"60_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima, G. K. & Morell, P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107\u2013116, https:\/\/doi.org\/10.1111\/j.1750-3639.2001.tb00385.x (2001).","journal-title":"Brain Pathol."},{"key":"60_CR24","doi-asserted-by":"publisher","unstructured":"Sachs, H. H., Bercury, K. K., Popescu, D. C., Narayanan, S. P. & Macklin, W. B. A new model of cuprizone-mediated demyelination\/remyelination. ASN Neuro 6, https:\/\/doi.org\/10.1177\/1759091414551955 (2014).","DOI":"10.1177\/1759091414551955"},{"key":"60_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.expneurol.2016.06.033","volume":"283","author":"CB Bai","year":"2016","unstructured":"Bai, C. B. et al. A mouse model for testing remyelinating therapies. Exp. Neurol. 283, 330\u2013340, https:\/\/doi.org\/10.1016\/j.expneurol.2016.06.033 (2016).","journal-title":"Exp. Neurol."},{"key":"60_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nn1460","volume":"8","author":"S Mi","year":"2005","unstructured":"Mi, S. et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 8, 745\u2013751, https:\/\/doi.org\/10.1038\/nn1460 (2005).","journal-title":"Nat. Neurosci."},{"key":"60_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000417","volume":"5","author":"A Ranger","year":"2018","unstructured":"Ranger, A. et al. Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies. Neurol. Neuroimmunol. Neuroinflamm 5, e417. https:\/\/doi.org\/10.1212\/NXI.0000000000000417 (2018).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"60_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","volume":"18","author":"D Cadavid","year":"2019","unstructured":"Cadavid, D. et al. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 18, 845\u2013856, https:\/\/doi.org\/10.1016\/S1474-4422(19)30137-1 (2019).","journal-title":"Lancet Neurol."},{"key":"60_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11011-015-9781-y","volume":"31","author":"A Zendedel","year":"2016","unstructured":"Zendedel, A. et al. Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice. Metab. Brain Dis. 31, 425\u2013433, https:\/\/doi.org\/10.1007\/s11011-015-9781-y (2016).","journal-title":"Metab. Brain Dis."},{"key":"60_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep45780","volume":"7","author":"C Eleuteri","year":"2017","unstructured":"Eleuteri, C. et al. A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials. Sci. Rep. 7, 45780. https:\/\/doi.org\/10.1038\/srep45780 (2017).","journal-title":"Sci. Rep."},{"key":"60_CR31","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green, A. J. et al. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390, 2481\u20132489, https:\/\/doi.org\/10.1016\/S0140-6736(17)32346-2 (2017).","journal-title":"Lancet"},{"key":"60_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm, F. J. et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature 522, 216\u2013220, https:\/\/doi.org\/10.1038\/nature14335 (2015).","journal-title":"Nature"},{"key":"60_CR33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","volume":"560","author":"Z Hubler","year":"2018","unstructured":"Hubler, Z. et al. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature 560, 372\u2013376, https:\/\/doi.org\/10.1038\/s41586-018-0360-3 (2018).","journal-title":"Nature"},{"key":"60_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2024.108820","volume":"132","author":"T Hartley","year":"2025","unstructured":"Hartley, T. et al. Embryotoxicity of statins and other prescribed drugs with reported off-target effects on cholesterol biosynthesis. Reprod. Toxicol. 132, 108820. https:\/\/doi.org\/10.1016\/j.reprotox.2024.108820 (2025).","journal-title":"Reprod. Toxicol."},{"key":"60_CR35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41589-022-01115-2","volume":"18","author":"AV Caprariello","year":"2022","unstructured":"Caprariello, A. V. & Adams, D. J. The landscape of targets and lead molecules for remyelination. Nat. Chem. Biol. 18, 925\u2013933, https:\/\/doi.org\/10.1038\/s41589-022-01115-2 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"60_CR36","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1523\/JNEUROSCI.22-03-00876.2002","volume":"22","author":"BS Mallon","year":"2002","unstructured":"Mallon, B. S., Shick, H. E., Kidd, G. J. & Macklin, W. B. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci. 22, 876\u2013885, https:\/\/doi.org\/10.1523\/JNEUROSCI.22-03-00876.2002 (2002).","journal-title":"J. Neurosci."},{"key":"60_CR37","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1073\/pnas.052704499","volume":"99","author":"L Calza","year":"2002","unstructured":"Calza, L., Fernandez, M., Giuliani, A., Aloe, L. & Giardino, L. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 99, 3258\u20133263, https:\/\/doi.org\/10.1073\/pnas.052704499 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67\u201373, https:\/\/doi.org\/10.1177\/108705719900400206 (1999).","journal-title":"J. Biomol. Screen"},{"key":"60_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","volume":"7","author":"TT Wager","year":"2016","unstructured":"Wager, T. T., Hou, X., Verhoest, P. R. & Villalobos, A. Central nervous system multiparameter optimization desirability: application in drug discovery. ACS Chem. Neurosci. 7, 767\u2013775, https:\/\/doi.org\/10.1021\/acschemneuro.6b00029 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"60_CR40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/brain\/awae311","volume":"148","author":"QL Cui","year":"2025","unstructured":"Cui, Q. L. et al. Myelination potential and injury susceptibility of grey versus white matter human oligodendrocytes. Brain 148, 921\u2013932, https:\/\/doi.org\/10.1093\/brain\/awae311 (2025).","journal-title":"Brain"},{"key":"60_CR41","doi-asserted-by":"publisher","unstructured":"Swinney, D. C. & Lee, J. A. Recent advances in phenotypic drug discovery. F1000Res 9, https:\/\/doi.org\/10.12688\/f1000research.25813.1 (2020).","DOI":"10.12688\/f1000research.25813.1"},{"key":"60_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrd4336","volume":"13","author":"J Eder","year":"2014","unstructured":"Eder, J., Sedrani, R. & Wiesmann, C. The discovery of first-in-class drugs: origins and evolution. Nat. Rev. Drug Discov. 13, 577\u2013587, https:\/\/doi.org\/10.1038\/nrd4336 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"60_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.04.010","volume":"164","author":"DP Katz","year":"2016","unstructured":"Katz, D. P. et al. Benzylpiperazine: \u201ca messy drug\u201d. Drug Alcohol Depend. 164, 1\u20137, https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.04.010 (2016).","journal-title":"Drug Alcohol Depend."},{"key":"60_CR44","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1021\/jm0208875","volume":"45","author":"A Cavalli","year":"2002","unstructured":"Cavalli, A., Poluzzi, E., De Ponti, F. & Recanatini, M. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. J. Med. Chem. 45, 3844\u20133853, https:\/\/doi.org\/10.1021\/jm0208875 (2002).","journal-title":"J. Med. Chem."},{"key":"60_CR45","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1101\/gad.1806309","volume":"23","author":"SP Fancy","year":"2009","unstructured":"Fancy, S. P. et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23, 1571\u20131585, https:\/\/doi.org\/10.1101\/gad.1806309 (2009).","journal-title":"Genes Dev."},{"key":"60_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2005.03.027","volume":"233","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg, A. & Lassmann, H. Cortical lesions and brain atrophy in MS. J. Neurol. Sci. 233, 55\u201359, https:\/\/doi.org\/10.1016\/j.jns.2005.03.027 (2005).","journal-title":"J. Neurol. Sci."},{"key":"60_CR47","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ana.23693","volume":"72","author":"A Chang","year":"2012","unstructured":"Chang, A. et al. Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann. Neurol. 72, 918\u2013926, https:\/\/doi.org\/10.1002\/ana.23693 (2012).","journal-title":"Ann. Neurol."},{"key":"60_CR48","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1021\/jm060379l","volume":"49","author":"C Jamieson","year":"2006","unstructured":"Jamieson, C., Moir, E. M., Rankovic, Z. & Wishart, G. Medicinal chemistry of hERG optimizations: Highlights and hang-ups. J. Med. Chem. 49, 5029\u20135046, https:\/\/doi.org\/10.1021\/jm060379l (2006).","journal-title":"J. Med. Chem."},{"key":"60_CR49","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1101\/pdb.top074898","volume":"2013","author":"JC Dugas","year":"2013","unstructured":"Dugas, J. C. & Emery, B. Purification and culture of oligodendrocyte lineage cells. Cold Spring Harb. Protoc. 2013, 810\u2013814, https:\/\/doi.org\/10.1101\/pdb.top074898 (2013).","journal-title":"Cold Spring Harb. Protoc."},{"key":"60_CR50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.137.2.459","volume":"137","author":"BD Trapp","year":"1997","unstructured":"Trapp, B. D., Nishiyama, A., Cheng, D. & Macklin, W. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J. Cell Biol. 137, 459\u2013468, https:\/\/doi.org\/10.1083\/jcb.137.2.459 (1997).","journal-title":"J. Cell Biol."}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00060-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00060-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:20:27Z","timestamp":1784791227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00060-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00060-7","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"24"}}